Combining PD-1 or PD-L1 inhibitors with chemotherapy is a good strategy for the treatment of extensive small cell lung cancer: A retrospective analysis of clinical studies

OBJECTIVES: To provide an updated systematic review and meta-analysis of published randomized controlled trials (RCTs) of the efficacy and safety of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors combined with chemotherapy versus chemotherapy alone in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hao, Song, Guangbin, Wang, Dong, Li, Mengxia, Dai, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760880/
https://www.ncbi.nlm.nih.gov/pubmed/36544769
http://dx.doi.org/10.3389/fimmu.2022.1059557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760880/
https://www.ncbi.nlm.nih.gov/pubmed/36544769
http://dx.doi.org/10.3389/fimmu.2022.1059557

Ejemplares similares